Tocqueville Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,600	Closed	-$83.4K	–	550
2025 Q4	$83.4K	Sell	13,600 -12,900	-49%	-$139K	﹤0.01%	573
2025 Q3	$488K	Sell	26,500 -2,200	-8%	-$35.3K	0.01%	435
2025 Q2	$373K	Buy	28,700 +5,300	+23%	+$62.7K	0.01%	450
2025 Q1	$248K	Buy	23,400 +1,000	+4%	+$15.9K	﹤0.01%	480
2024 Q4	$380K	Buy	22,400 +6,700	+43%	+$126K	0.01%	453
2024 Q3	$364K	Buy	15,700 +1,700	+12%	+$36.4K	0.01%	442
2024 Q2	$341K	Sell	14,000 -500	-3%	-$15.2K	0.01%	444
2024 Q1	$490K	Sell	14,500 -1,400	-9%	-$49.6K	0.01%	412
2023 Q4	$501K	Buy	15,900 +600	+4%	+$14.3K	0.01%	401
2023 Q3	$391K	Buy	15,300 +2,200	+17%	+$67.8K	0.01%	421
2023 Q2	$376K	Sell	13,100 -5,100	-28%	-$139K	0.01%	435
2023 Q1	$436K	Buy	+18,200	New	+$327K	0.01%	425
2020 Q2	–	Sell	-10,450	Closed	-$142K	–	653
2020 Q1	$142K	Buy	+10,450	New	+$134K	﹤0.01%	610